Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome–associated progressive multifocal leukoencephalopathy

REFERENCES

• Antinori A, Ammassari A, Giancola M L, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J NeuroVirol 2001; 7: 323–328, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Antinori A, Cingolani A, Lorenzini P, Giancola M L, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, DelGrosso B, Arcidiacono M I, Fibbia G C, Mena M, Finazzi M G, Guaraldi G, Ammassari A, D'ArminioMonforte A, Cinque P, De Luca A, Italian Registry Investigative Neuro AIDS Study Group. Clinical epidemiology and survival of progressive multifocal leucoencepalophathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J NeuroVirol 2003; 9(Suppl 1)47–54, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Berenguer J, Miralles P, Arrizabalaga J, Ribera E, Dronda F, Baraia-Etxaburu J, Domingo P, Marquez M, Rodriguez-Arrondo F J, Laguna F, Rubio R, LacruzRodrigo J, Mallolas J, de Miguel V, GESIDA 11/99 Study Group. Clinical course and prognostic factors of AIDS-associated progressive multifocal leukoencepalophathy in patients treated with higly active antiretroviral therapy. Clin Infect Dis 2003; 36: 1047–1052, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Berger J R, Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J NeuroVirol 1995; 1: 5–18, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Berger J R, Kaszovitz B, Post M J, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 1987; 107: 78–87, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bernasconi S, Cinque P, Peri G, Sozzani S, Crociati A, Torri W, Vicenzi E, Vago L, Lazzarin A, Poli G, Mantovani A. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J Infect Dis 1996; 174: 1098–1101, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Brooks B R, Walker D L. Progressive multifocal leukoencepalophathy. Neurol Clin 1984; 2: 299–313, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bruno V, Copani A, Besong G, Scoto G, Nicoletti F. Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur J Pharmacol 2000; 399: 117–121, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, St Hillaire C, Conant K. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients. Antiviral Therapy 2004; 9: 431–440, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cinque P, Bossolasco S, Brambilla A M, Boschini A, Mussini C, Pierotti C, Campi A, Casari S, Bertelli D, Mena M, Lazzarin A. The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with rewiew of the literature. J NeuroVirol 2003; 9(Suppl 1)73–80, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Cinque P, Pierotti C, Viganò M G, Bestetti A, Fausti C, Bertelli D, Lazzarin A. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J NeuroVirol 2001; 7: 358–363, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, Transidico P, Vagani A, Sozzani S, Mantovani A, Lazzarin A, Poli G. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998; 12: 1327–1332, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Conant K, Garzino-Demo A, Nath A, McArthur J C, Halliday W, Power C, Gallo M C, Major E O. Induction of monocyte chemoattractant protein-1 HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A 1998; 95: 3117–3121, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• De Luca A, Ammassari A, Cingolani A, Giancola M L, Antinori A. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencepalophathy despite highly active antiretroviral therapy. AIDS 1998; 12: 1937–1938, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola M L, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G, Cauda R, Monforte A, Antinori A. Potent antiretroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencepalophathy: extended follow-up and an observational study. J NeuroVirol 2001; 7: 364–368, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola M L, Ammassari A, Grisetti S, Paglia M G, Gentile M, Cingolani A, Murri R, Liuzzi G, Monforte A D, Antinori A. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencepalophathy. J Infect Dis 2000; 182: 1077–1083, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola M L, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS associated progressive multifocal leukoencepalophathy. Clin Infect Dis 1999; 28: 624–628, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Di Giambenedetto S, Vago L, Pompucci A, Scoppettuolo G, Cingolani A, Marzocchetti A, Tumbarello M, Cauda R, De Luca A. Fatal imflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?. Neurology 2004; 63: 2452–2453, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Du Pasquier R A, Koralnik I J. Inflammatory reaction in progressive multifocal leukoencepalophathy: Harmful or beneficial?. J Neurovirol 2003; 9(Suppl 1)25–32, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Eugenin E A, D'Aversa T G, Lopez L, Calderon T M, Berman J W. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 2003; 85: 1299–1311, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gasnault J, Kahraman M, Ghislaine M G, Durali D, Delfraissy J F, Taoufik J. Crititcal role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoancephalopathy. AIDS 2003; 17: 1443–1449, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gasnault J, Kousignian P, Kahraman M, Rahoiljaon J, Matheron S, Delfraissy J F, Taoufik Y. Cidofovir in AIDS-associated progressive multifocal leukoencepalophathy: a monocenter observational study with clinical and JC virus load monitoring. J NeuroVirol 2001; 7: 375–381, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gasnault J, Taoufik Y, Bentala M, Kousignian P, Abbed K, Boue F, Dussaix E, Delfraissy J F. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J NeuroVirol 1999; 5: 421–429, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gisolf E H, Van Praag R M, Jurriaans S, Portegies P, Goudsmit J, Danner S A, Lange J M, Prins J M. Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 25: 426–433, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla A M, Luke W, Lazzarin A, Weber T, Cinque P. Highly active antiretroviral therapy and progressive multifocal leukoancephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 2000; 30: 95–99, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Katz-Brull R, Lenkinski R E, Du Pasquier R A, Koralnik I J. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 2004; 63: 897–900, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kitai R, Zhao M L, Zhang N, Hua L L, Lee S C. IP beta and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNbeta. J Neuroimmunol 2000; 110: 230–239, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Major E O, Amemiya K, Tornatore C S, Houff S A, Berger J R. Pathogenesis and molecular biology of Progressive Multifocal leukoencepalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992; 5: 49–73, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McManus C M, Weidenheim K, Woodman S E, Nunez J, Hesselgesser J, Nath A, Berman J W. Chemokine and chemokine receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 2000; 156: 1441–1453, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez J C, Padilla B, Munoz L, Garcia-de-Viedma D. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 2001; 15: 1900–1902, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nardese V, Longhi R, Polo S, Sironi F, Arcelloni C, Paroni R, DeSantis C, Sarmientos P, Rizzi M, Bolognesi M, Pavone V, Lusso P. Structural determinant of CCR5 recognition and HIV-1 blockade in RANTES. Nat Struct Biol 2001; 8: 611–615, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Palella F J, Delaney K M, Moorman A C, Loveless M O, Fuhrer J, Satten G A, Aschman D J, Holmberg S D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatients Study Investigators. N Engl J Med 1998; 338: 853–860, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vilcek J, Lee T H. Tumor necrosis factor. New insight into the molecular mechanisms of its multiple actions. J Biol Chem 1991; 266: 7313–7316, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar